Cargando…

Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases

PURPOSE: Lymphomas of the orbit and ocular adnexa are histologically heterogeneous and their incidence rate has been increasing lately. However, because of their rarity and diversity, few cases have been analyzed. This study evaluated patients with orbital and ocular adnexal mucosa-associated lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liping, Tang, Xinyu, Jiang, Nan, Zhang, Sheng, Cao, Yuandong, Sun, Xinchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544123/
https://www.ncbi.nlm.nih.gov/pubmed/34707410
http://dx.doi.org/10.2147/CMAR.S334396
_version_ 1784589755162296320
author Xu, Liping
Tang, Xinyu
Jiang, Nan
Zhang, Sheng
Cao, Yuandong
Sun, Xinchen
author_facet Xu, Liping
Tang, Xinyu
Jiang, Nan
Zhang, Sheng
Cao, Yuandong
Sun, Xinchen
author_sort Xu, Liping
collection PubMed
description PURPOSE: Lymphomas of the orbit and ocular adnexa are histologically heterogeneous and their incidence rate has been increasing lately. However, because of their rarity and diversity, few cases have been analyzed. This study evaluated patients with orbital and ocular adnexal mucosa-associated lymphoid tissue (OAMALT), who received radiotherapy, and categorized their clinical characteristics, treatment outcomes, and complications. PATIENTS AND METHODS: We collected data on clinical presentation, age, sex, imaging, tumor location, treatment methods, pathological diagnosis, cataract incidence, cataract incidence periods, overall survival (OS), and disease-free survival (DFS) from 32 patients with orbital involvement and pathologically confirmed marginal zone B-cell lymphoma of MALT who were treated between 2009 and 2018. Twenty-two patients received 20 Gy/10 Fr using intensity-modulated radiation therapy (IMRT) plus 14 Gy/7 Fr using a 6–14-MeV electron beam therapy using a lens-sparing approach. Ten patients received 32 Gy/16 Fr or 34 Gy/17 Fr using IMRT without the lens shield technique. Kaplan–Meier analysis was used to estimate DFS and OS. RESULTS: The median follow-up time was 83.4 ± 24.5 months. No patient had local recurrence, although three patients developed distant metastases. The 5-year and 10-year OS rates were both 100%. The 5-year and 10-year DFS rates were 96.7% and 74.2%, respectively. Overall, 11 (32.4%) of the 34 lenses developed cataracts. The estimated 5-year, 7-year, and 10-year cumulative cataract rates were 6.9%, 30.9%, and 60.8%, respectively. The median cumulative cataract incidence period was 107.0 months. Age was the only significant parameter associated with cataract formation. CONCLUSION: A radiation dose of 32–34 Gy yields excellent local control, DFS, and OS for OAMALT. Some patients may have systemic relapse, and better identification of these patients is necessary. Reducing the prescription radiation dose or using better radiation techniques to spare the ipsilateral lens could reduce cataract formation.
format Online
Article
Text
id pubmed-8544123
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85441232021-10-26 Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases Xu, Liping Tang, Xinyu Jiang, Nan Zhang, Sheng Cao, Yuandong Sun, Xinchen Cancer Manag Res Original Research PURPOSE: Lymphomas of the orbit and ocular adnexa are histologically heterogeneous and their incidence rate has been increasing lately. However, because of their rarity and diversity, few cases have been analyzed. This study evaluated patients with orbital and ocular adnexal mucosa-associated lymphoid tissue (OAMALT), who received radiotherapy, and categorized their clinical characteristics, treatment outcomes, and complications. PATIENTS AND METHODS: We collected data on clinical presentation, age, sex, imaging, tumor location, treatment methods, pathological diagnosis, cataract incidence, cataract incidence periods, overall survival (OS), and disease-free survival (DFS) from 32 patients with orbital involvement and pathologically confirmed marginal zone B-cell lymphoma of MALT who were treated between 2009 and 2018. Twenty-two patients received 20 Gy/10 Fr using intensity-modulated radiation therapy (IMRT) plus 14 Gy/7 Fr using a 6–14-MeV electron beam therapy using a lens-sparing approach. Ten patients received 32 Gy/16 Fr or 34 Gy/17 Fr using IMRT without the lens shield technique. Kaplan–Meier analysis was used to estimate DFS and OS. RESULTS: The median follow-up time was 83.4 ± 24.5 months. No patient had local recurrence, although three patients developed distant metastases. The 5-year and 10-year OS rates were both 100%. The 5-year and 10-year DFS rates were 96.7% and 74.2%, respectively. Overall, 11 (32.4%) of the 34 lenses developed cataracts. The estimated 5-year, 7-year, and 10-year cumulative cataract rates were 6.9%, 30.9%, and 60.8%, respectively. The median cumulative cataract incidence period was 107.0 months. Age was the only significant parameter associated with cataract formation. CONCLUSION: A radiation dose of 32–34 Gy yields excellent local control, DFS, and OS for OAMALT. Some patients may have systemic relapse, and better identification of these patients is necessary. Reducing the prescription radiation dose or using better radiation techniques to spare the ipsilateral lens could reduce cataract formation. Dove 2021-10-21 /pmc/articles/PMC8544123/ /pubmed/34707410 http://dx.doi.org/10.2147/CMAR.S334396 Text en © 2021 Xu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Xu, Liping
Tang, Xinyu
Jiang, Nan
Zhang, Sheng
Cao, Yuandong
Sun, Xinchen
Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases
title Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases
title_full Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases
title_fullStr Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases
title_full_unstemmed Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases
title_short Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases
title_sort radiation therapy efficacy and toxicity for orbital and ocular adnexal mucosa-associated lymphoid tissue (oamalt): a single-center, retrospective study of 32 cases
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544123/
https://www.ncbi.nlm.nih.gov/pubmed/34707410
http://dx.doi.org/10.2147/CMAR.S334396
work_keys_str_mv AT xuliping radiationtherapyefficacyandtoxicityfororbitalandocularadnexalmucosaassociatedlymphoidtissueoamaltasinglecenterretrospectivestudyof32cases
AT tangxinyu radiationtherapyefficacyandtoxicityfororbitalandocularadnexalmucosaassociatedlymphoidtissueoamaltasinglecenterretrospectivestudyof32cases
AT jiangnan radiationtherapyefficacyandtoxicityfororbitalandocularadnexalmucosaassociatedlymphoidtissueoamaltasinglecenterretrospectivestudyof32cases
AT zhangsheng radiationtherapyefficacyandtoxicityfororbitalandocularadnexalmucosaassociatedlymphoidtissueoamaltasinglecenterretrospectivestudyof32cases
AT caoyuandong radiationtherapyefficacyandtoxicityfororbitalandocularadnexalmucosaassociatedlymphoidtissueoamaltasinglecenterretrospectivestudyof32cases
AT sunxinchen radiationtherapyefficacyandtoxicityfororbitalandocularadnexalmucosaassociatedlymphoidtissueoamaltasinglecenterretrospectivestudyof32cases